Application‑based Hemp Gummie segmentation identifies five distinct usage categories: wellness, sleep aid, pain relief, recreational, and dietary supplement. The wellness segment, encompassing general health maintenance and stress reduction, dominates with an estimated 35 % share, driven by broad consumer awareness of CBD's anxiolytic properties. Sleep‑aid gummies, formulated with added melatonin or valerian, capture roughly 25 % of sales, reflecting strong demand among adults seeking non‑pharmacologic sleep solutions. Pain‑relief products, often combined with anti‑inflammatory botanicals, hold a 20 % market portion, supported by clinical evidence of analgesic effects. Recreational use, limited by legal THC thresholds, contributes about 10 % and is concentrated in jurisdictions with permissive regulations. Finally, dietary‑supplement gummies—fortified with vitamins or minerals—represent the remaining 10 %, appealing to health‑focused consumers seeking multifunctional nutrition. These application segments collectively define the market’s revenue distribution and guide product development priorities.